News | Stroke | August 15, 2023

New Evidence Bolsters Theory E-cigarettes May Increase Stroke Risk

E-cigarettes likely not healthier alternative to traditional cigarettes 

E-cigarettes likely not healthier alternative to traditional cigarettes

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of stroke, according to researchers from the University of Colorado Boulder. Their study conducted in humans showed that circulating endothelial cell-derived microvesicles (tiny, bubble-like particles released into the bloodstream during inflammation) from e-cigarette users have adverse effects on key factors responsible for regulating brain blood flow. Changes in these factors contribute to the “promotion, development and progression” of ischemic stroke. These strokes are the most common type of stroke and are caused by a blockage cutting off the blood supply to the brain. The study is published in the Journal of Applied Physiology and has been chosen as an APSselect article for August.  

“The results of this study help us learn how e-cigarettes may affect the brain and contribute to the increased risk of stroke.” —Vinicius P. Garcia, PhD 

E-cigarette use is associated with a higher occurrence of stroke at a younger age. In this study, researchers examined 27 healthy young adults ages 19–25. The cohort was subdivided into 10 nonsmokers, 10 e-cigarette users and seven tobacco cigarette smokers. Researchers zeroed in on the possible effects of endothelial cell-derived microvesicles isolated from e-cigarette users on central factors associated with the regulation of brain blood flow and increased susceptibility to stroke. 

The mechanisms underlying e-cigarette-induced stroke remain unclear. Yet, interest in endothelial cell-derived microvesicles as a cause has intensified. Researchers suspect these microvesicles play a key role in stroke because their release into the bloodstream increases during e-cigarette use. 

“Studying the characteristics of circulating endothelial cell-derived microvesicles from e-cigarette users will help us learn more about how these products affect the brain and contribute to the risk of stroke,” said Vinicius P. Garcia, PhD, lead author of the study. “These results also lend support to the notion that e-cigarettes are not a healthier alternative to combustible tobacco cigarettes.” 

For more information: https://www.physiology.org/


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now